BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32003104)

  • 1. Impact of the protein corona on nanomaterial immune response and targeting ability.
    Digiacomo L; Pozzi D; Palchetti S; Zingoni A; Caracciolo G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1615. PubMed ID: 32003104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of surface chemistry and morphology of nanoparticles on protein corona formation.
    Bilardo R; Traldi F; Vdovchenko A; Resmini M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1788. PubMed ID: 35257495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein bio-corona: critical issue in immune nanotoxicology.
    Neagu M; Piperigkou Z; Karamanou K; Engin AB; Docea AO; Constantin C; Negrei C; Nikitovic D; Tsatsakis A
    Arch Toxicol; 2017 Mar; 91(3):1031-1048. PubMed ID: 27438349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No king without a crown--impact of the nanomaterial-protein corona on nanobiomedicine.
    Docter D; Strieth S; Westmeier D; Hayden O; Gao M; Knauer SK; Stauber RH
    Nanomedicine (Lond); 2015 Feb; 10(3):503-19. PubMed ID: 25707981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward the Specificity of Bare Nanomaterial Surfaces for Protein Corona Formation.
    Vianello F; Cecconello A; Magro M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocorona-induced modifications in engineered nanomaterial-cellular interactions impacting biomedical applications.
    Kobos L; Shannahan J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 May; 12(3):e1608. PubMed ID: 31788989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine.
    Cai R; Chen C
    Adv Mater; 2019 Nov; 31(45):e1805740. PubMed ID: 30589115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental dimensions of the protein corona.
    Wheeler KE; Chetwynd AJ; Fahy KM; Hong BS; Tochihuitl JA; Foster LA; Lynch I
    Nat Nanotechnol; 2021 Jun; 16(6):617-629. PubMed ID: 34117462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting the novel properties of protein coronas: emerging applications in nanomedicine.
    Hamad-Schifferli K
    Nanomedicine (Lond); 2015 May; 10(10):1663-74. PubMed ID: 26008198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials.
    O'Connell DJ; Bombelli FB; Pitek AS; Monopoli MP; Cahill DJ; Dawson KA
    Nanoscale; 2015 Oct; 7(37):15268-76. PubMed ID: 26324751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM).
    Westmeier D; Stauber RH; Docter D
    Toxicol Appl Pharmacol; 2016 May; 299():53-7. PubMed ID: 26592323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possibilities and Limitations of Different Separation Techniques for the Analysis of the Protein Corona.
    Weber C; Morsbach S; Landfester K
    Angew Chem Int Ed Engl; 2019 Sep; 58(37):12787-12794. PubMed ID: 30933405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the immunological interactions of engineered nanomaterials: Role of the bio-corona.
    Fadeel B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1798. PubMed ID: 36416023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applications.
    Johnston H; Brown D; Kermanizadeh A; Gubbins E; Stone V
    J Control Release; 2012 Dec; 164(3):307-13. PubMed ID: 22940205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Analysis of the Binding Function and Structural Organization of the Protein Corona.
    Zhang Y; Wu JLY; Lazarovits J; Chan WCW
    J Am Chem Soc; 2020 May; 142(19):8827-8836. PubMed ID: 32293877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Corona Formation Impacts Nanomaterials as Drug Carriers.
    Gupta MN; Roy I
    Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capillary Electrophoresis Mass Spectrometry Approaches for Characterization of the Protein and Metabolite Corona Acquired by Nanomaterials.
    Chetwynd AJ; Zhang W; Faserl K; Thorn JA; Lynch I; Ramautar R; Lindner HH
    J Vis Exp; 2020 Oct; (164):. PubMed ID: 33191929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revealing the immune perturbation of black phosphorus nanomaterials to macrophages by understanding the protein corona.
    Mo J; Xie Q; Wei W; Zhao J
    Nat Commun; 2018 Jun; 9(1):2480. PubMed ID: 29946125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How protein coronas determine the fate of engineered nanoparticles in biological environment.
    Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
    Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Crucial Role of Environmental Coronas in Determining the Biological Effects of Engineered Nanomaterials.
    Xu L; Xu M; Wang R; Yin Y; Lynch I; Liu S
    Small; 2020 Sep; 16(36):e2003691. PubMed ID: 32780948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.